scholarly journals Role of maternal elimination diets and human milk IgA in the development of cow's milk allergy in the infants

2013 ◽  
Vol 44 (1) ◽  
pp. 69-78 ◽  
Author(s):  
K. M. Järvinen ◽  
J. E. Westfall ◽  
M. S. Seppo ◽  
A. K. James ◽  
A. J. Tsuang ◽  
...  
2001 ◽  
Vol 31 (10) ◽  
pp. 1599-1606 ◽  
Author(s):  
L. Vila ◽  
K. Beyer ◽  
K.-M. Järvinen ◽  
P. Chatchatee ◽  
L. Bardina ◽  
...  

2016 ◽  
Vol 48 ◽  
pp. e245-e246
Author(s):  
P. Poli ◽  
F. Scavuzzo ◽  
L. Squassabia ◽  
L. Fiorica ◽  
E. Zini ◽  
...  

2015 ◽  
Vol 8 ◽  
pp. A124
Author(s):  
Beni Morgenstern ◽  
Cleonir Beck ◽  
Cristina Jacob ◽  
Andrea Gushken ◽  
Antonio Carlos Pastorino ◽  
...  

2004 ◽  
Vol 55 (2) ◽  
pp. 296-301 ◽  
Author(s):  
Pamela Österlund ◽  
Tanja Smedberg ◽  
Arja Hakulinen ◽  
Hannele Heikkilä ◽  
Kirsi-Marjut Järvinen

Pathogens ◽  
2021 ◽  
Vol 10 (10) ◽  
pp. 1328
Author(s):  
Mika Ogata ◽  
Jun Kido ◽  
Kimitoshi Nakamura

Cow’s milk allergy (CMA) is one of the most common IgE-dependent food allergies in children. Some children develop severe and persistent CMA, with near-fatal reactions after exposure to trace amounts of cow’s milk (CM). Because milk and dairy products are included in various processed food products, it is difficult to completely remove milk, which negatively affects the quality of life of children with CMA. Oral immunotherapy (OIT) can alleviate food allergen-induced anaphylaxis under continuous ingestion of a little of the causative food. Children with severe CMA may benefit from OIT, but the treatment requires a long time and poses a risk of anaphylaxis. Moreover, in recent years, new therapies, including omalizumab, sublingual immunotherapy, and epicutaneous immunotherapy, have played the role of optional OIT. In this review, we present the current methods of and other attempts at OIT, and discuss OIT for safely treating CMA.


2000 ◽  
Vol 48 (4) ◽  
pp. 457-462 ◽  
Author(s):  
Kirsi-Marjut Jêvinen ◽  
Seppo T Laine ◽  
Anna-Liisa Jêvenpêê ◽  
Hanna K Suomalainen

2017 ◽  
Vol 139 (2) ◽  
pp. 708-711.e5 ◽  
Author(s):  
Antti E. Seppo ◽  
Chloe A. Autran ◽  
Lars Bode ◽  
Kirsi M. Järvinen

Sign in / Sign up

Export Citation Format

Share Document